|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.31 USD | +2.01% |
|
-11.54% | -27.56% |
| 14/07 | Tarsus Pharmaceuticals, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
| 14/07 | Tarsus Pharmaceuticals Appoints Neera Clase as Interim Chief Commercial Officer | MT |
| Market Cap | 255.18Cr 223.81Cr 207.29Cr 190.73Cr 360.76Cr 24TCr 367.78Cr 2.47TCr 969Cr 12TCr 958.21Cr 937.26Cr 41TCr | P/E 2026 * |
-51.5x | P/E 2027 * | 19.9x |
|---|---|---|---|---|---|
| Enterprise Value | 255.18Cr 223.81Cr 207.29Cr 190.73Cr 360.76Cr 24TCr 367.78Cr 2.47TCr 969Cr 12TCr 958.21Cr 937.26Cr 41TCr | EV / Sales 2026 * |
3.64x | EV / Sales 2027 * | 2.82x |
| Free-Float |
96.94% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Tarsus Pharmaceuticals, Inc.
| 1 day | +2.01% | ||
| 1 week | -11.54% | ||
| Current month | -5.77% | ||
| 1 month | -4.26% | ||
| 3 months | -18.36% | ||
| 6 months | -21.68% | ||
| Current year | -27.56% |
| 1 week | 56.96 | 70.68 | |
| 1 month | 56.51 | 72.5 | |
| Current year | 56 | 83.92 | |
| 1 year | 38.51 | 85.25 | |
| 3 years | 12.57 | 85.25 | |
| 5 years | 10.8 | 85.25 | |
| 10 years | 10.8 | 85.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CEO | Chief Executive Officer | 48 | 01/09/2018 |
Jeffrey Farrow
DFI | Director of Finance/CFO | 64 | 24/04/2023 |
| Chief Tech/Sci/R&D Officer | 47 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bobak Azamian
CHM | Chairman | 48 | 02/12/2022 |
| Director/Board Member | 71 | 01/12/2019 | |
Bill Link
BRD | Director/Board Member | 80 | 01/01/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/06 | Free | Director | 7,060 | 0.0164% | ||
| 25/06 | Free | Director | 6,254 | 0.0145% | ||
| 25/06 | Free | Director | 6,254 | 0.0145% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.01% | -11.54% | +51.38% | +238.33% | 255.18Cr | ||
| -0.22% | +2.04% | +16.79% | -8.03% | 6.75TCr | ||
| -1.02% | -8.04% | +35.27% | +194.25% | 5.11TCr | ||
| +0.36% | +40.00% | +40.00% | +40.00% | 4.34TCr | ||
| +1.34% | -0.81% | -49.11% | -52.89% | 4.03TCr | ||
| +4.96% | +0.27% | +55.75% | -24.80% | 3.09TCr | ||
| -1.85% | -18.08% | +99.20% | -47.07% | 2.66TCr | ||
| -2.12% | -1.20% | +66.54% | +84.42% | 2.28TCr | ||
| +1.07% | +3.27% | +9.82% | +177.50% | 1.98TCr | ||
| -0.78% | -4.46% | +55.18% | +125.37% | 1.65TCr | ||
| Average | +0.77% | -4.42% | +38.08% | +72.71% | 3.21TCr | |
| Weighted average by Cap. | +0.56% | -3.12% | +30.50% | +46.95% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 70Cr 61Cr 57Cr 52Cr 99Cr 6.71TCr 101.06Cr 678.86Cr 266.25Cr 3.3TCr 263.29Cr 257.53Cr 11TCr | 91Cr 79Cr 74Cr 68Cr 128.14Cr 8.68TCr 130.64Cr 877.58Cr 344.19Cr 4.26TCr 340.36Cr 332.92Cr 15TCr |
| Net income | -5.56Cr -4.87Cr -4.51Cr -4.15Cr -7.86Cr -531.87Cr -8.01Cr -54Cr -21Cr -261.19Cr -21Cr -20Cr -902.01Cr | 15Cr 13Cr 12Cr 11Cr 21Cr 1.46TCr 22Cr 147.19Cr 58Cr 714.52Cr 57Cr 56Cr 2.47TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | $59.31 | +2.01% | 11,13,250 |
| 10/26/10 | $58.14 | -9.35% | 23,67,158 |
| 09/26/09 | $64.14 | -5.30% | 21,68,792 |
| 08/26/08 | $67.73 | -4.00% | 13,30,643 |
| 07/26/07 | $70.55 | +5.22% | 16,85,124 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARS Stock
Select your edition
All financial news and data tailored to specific country editions

















